We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
We begin a new week of trading in the green, following a courageous fight-back late last week in the Nasdaq and S&P 500, where a pull-back last Thursday morning on weak jobless claims and Q2 GDP reminded investors we’re still in the midst of major economic challenges. The Nasdaq looks to open at a fresh all-time high. The Dow has yet to climb fully back to pre-Thursday levels.
These challenges continue, particularly in the Retail sector: high-end apparel company Lord & Taylor has at last filed for Chapter 11 bankruptcy protection. Tailored Brands , parent company of Men’s Wearhouse and Jos. A. Bank, follows “suit.” These latest victims of the economic strain due to our pandemic crisis — now roughly half a year since it began in this country — come after noteworthy bankruptcies from name brands Neiman Marcus, J. Crew and J.C. Penney.
Speaking of the pandemic, worldwide cases are once again picking up steam, even as some of the major hot spots in the U.S. appear to be tapering off a bit. We now see 18 million reported cases with 690K fatalities globally, with 4.75 million cases reported so far in the U.S., with 157K Americans having succumbed to the disease. In fact, nearly one in four fatalities related to COVID-19 have occurred here at home — and this was supposed to be the “down period” of the disease before a “second wave” comes this fall.
Meanwhile, we continue to await Congress agreeing on new relief package for Americans economically affected by the pandemic; its predecessor, The CARES Act, expired last week. The Republican-run Senate and the Democratic-led House are still at something resembling a stalemate regarding how much money (and where to apply it) will be allocated before depression-like conditions begin to take hold for the tens of millions out of work, many since the pandemic began.
This will be a big week for jobs numbers — not just Thursday’s Initial and Continuing Claims, but Wednesday we see private-sector payroll numbers from ADP (ADP - Free Report) and Friday is the biggie: non-farm payrolls from the U.S. Bureau of Labor Statistics. Analyst will be looking for the third straight month of positive jobs gains, adding to the 7.5 million jobs having been created in May and June. This, of course, follows the massive drop of 20.7 million jobs reported for April.
Otherwise, we see plenty more Q2 earnings reports this week, from big industry leaders like Disney (DIS - Free Report) , T-Mobile (TMUS - Free Report) , CVS (CVS - Free Report) and Activision . We’re through Big Tech and not quite to Retail reports yet, but we are starting the “back nine” of earnings season at this stage.
Zacks Rank #2 (Buy)-rated Clorox (CLX - Free Report) topped estimates for its fiscal Q4 report this morning, posting earnings of $2.41 per share which beat the Zacks consensus of $2.00. Revenues of $1.98 billion for the Consumer Staples major outperformed expectations by 6.75%. But shares are selling off a bit on the news and lowered guidance -- and that of the company changing CEOs -- following year-to-date stock performance of +54%.
Tyson Foods (TSN - Free Report) , also rated Zacks Rank #2 ahead of its fiscal Q3 earnings release this morning, beat earnings estimates by a wide margin: $1.40 per shares versus 90 cents expected. However, sales of $10.02 billion in the quarter missed the Zacks consensus by 5.5%, and was down notably from the $10.89 billion posted in the year-ago quarter. Shares are up 2.5% in the pre-market, however; Tyson had been down 32.5% year to date.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Wall Street Northbound Despite Several Concerns
We begin a new week of trading in the green, following a courageous fight-back late last week in the Nasdaq and S&P 500, where a pull-back last Thursday morning on weak jobless claims and Q2 GDP reminded investors we’re still in the midst of major economic challenges. The Nasdaq looks to open at a fresh all-time high. The Dow has yet to climb fully back to pre-Thursday levels.
These challenges continue, particularly in the Retail sector: high-end apparel company Lord & Taylor has at last filed for Chapter 11 bankruptcy protection. Tailored Brands , parent company of Men’s Wearhouse and Jos. A. Bank, follows “suit.” These latest victims of the economic strain due to our pandemic crisis — now roughly half a year since it began in this country — come after noteworthy bankruptcies from name brands Neiman Marcus, J. Crew and J.C. Penney.
Speaking of the pandemic, worldwide cases are once again picking up steam, even as some of the major hot spots in the U.S. appear to be tapering off a bit. We now see 18 million reported cases with 690K fatalities globally, with 4.75 million cases reported so far in the U.S., with 157K Americans having succumbed to the disease. In fact, nearly one in four fatalities related to COVID-19 have occurred here at home — and this was supposed to be the “down period” of the disease before a “second wave” comes this fall.
Meanwhile, we continue to await Congress agreeing on new relief package for Americans economically affected by the pandemic; its predecessor, The CARES Act, expired last week. The Republican-run Senate and the Democratic-led House are still at something resembling a stalemate regarding how much money (and where to apply it) will be allocated before depression-like conditions begin to take hold for the tens of millions out of work, many since the pandemic began.
This will be a big week for jobs numbers — not just Thursday’s Initial and Continuing Claims, but Wednesday we see private-sector payroll numbers from ADP (ADP - Free Report) and Friday is the biggie: non-farm payrolls from the U.S. Bureau of Labor Statistics. Analyst will be looking for the third straight month of positive jobs gains, adding to the 7.5 million jobs having been created in May and June. This, of course, follows the massive drop of 20.7 million jobs reported for April.
Otherwise, we see plenty more Q2 earnings reports this week, from big industry leaders like Disney (DIS - Free Report) , T-Mobile (TMUS - Free Report) , CVS (CVS - Free Report) and Activision . We’re through Big Tech and not quite to Retail reports yet, but we are starting the “back nine” of earnings season at this stage.
Zacks Rank #2 (Buy)-rated Clorox (CLX - Free Report) topped estimates for its fiscal Q4 report this morning, posting earnings of $2.41 per share which beat the Zacks consensus of $2.00. Revenues of $1.98 billion for the Consumer Staples major outperformed expectations by 6.75%. But shares are selling off a bit on the news and lowered guidance -- and that of the company changing CEOs -- following year-to-date stock performance of +54%.
Tyson Foods (TSN - Free Report) , also rated Zacks Rank #2 ahead of its fiscal Q3 earnings release this morning, beat earnings estimates by a wide margin: $1.40 per shares versus 90 cents expected. However, sales of $10.02 billion in the quarter missed the Zacks consensus by 5.5%, and was down notably from the $10.89 billion posted in the year-ago quarter. Shares are up 2.5% in the pre-market, however; Tyson had been down 32.5% year to date.